E Bertoldi

Plain English
This research looks at two methods of pacing used to treat heart failure: conduction system pacing (CSP) and biventricular pacing (BVP). The study involves 179 patients over a year and aims to see which method is more cost-effective, with a focus on the total medical costs for each patient. The findings could help make heart failure treatments more affordable and accessible, particularly in Brazil, which may also benefit other healthcare systems globally. Who this helps: Patients with heart failure and the healthcare system.

Plain English
This study looked at whether using daily automated text messages could help heart failure patients stay healthy after they've been hospitalized. Out of 699 patients, those who received the text messages showed a significant increase in their self-care scores compared to those who received standard care, but their heart health markers didn’t improve significantly. This matters because, while the text messaging was well-received, it did not lead to better clinical outcomes, highlighting the need for more effective strategies. Who this helps: This helps heart failure patients managing their recovery after hospitalization.

Plain English
This study looked at the cost-effectiveness of using a device that measures carbon dioxide levels in the breath (capnography) during cardiac arrests in hospitals outside of intensive care units or emergency rooms. The researchers found that using capnography made CPR more effective, leading to one additional patient successfully regaining heart function for every estimated cost of about $515, with further benefits seen in hospital discharges and neurological outcomes. This is important because it shows that in hospitals in middle-income countries, using capnography can be a smart investment to improve patient outcomes during emergencies. Who this helps: Patients who suffer cardiac arrests in hospitals.

Plain English
This study looked at the use of a medical treatment called venoarterial extracorporeal membrane oxygenation (VA-ECMO) for patients with severe heart problems that don’t respond to other treatments. Researchers in Brazil found that using VA-ECMO along with standard care costs about $37,491 for each additional year of healthy life it provides. This is important because it shows that VA-ECMO may be a cost-effective option for treating critically ill patients in Brazil, which could help improve survival rates without overwhelming healthcare budgets. Who this helps: This benefits patients suffering from severe heart issues and the healthcare systems treating them.

Plain English
This study focused on a treatment for pancreatic cancer using a method called photodynamic therapy (PDT) with a substance called methylene blue. The researchers found that this treatment caused significant cell death in pancreatic cancer cells, with certain cancer models being more responsive than others. They also discovered that activating a specific type of cell death, known as necroptosis, made the treatment even more effective. This is important because it could improve outcomes for patients by reducing the chances of cancer returning after surgery. Who this helps: This benefits patients with pancreatic cancer.

Plain English
This study looked at how to make more environmentally friendly materials by using coffee silver skin, a byproduct from coffee production, as a filler in a mixture of biodegradable plastics. Researchers found that treating this filler with boiling water improved its performance significantly, leading to better strength and durability—specifically, a 172% increase in impact energy compared to untreated versions. This is important because it shows that waste materials can be used to create stronger, greener packaging options. Who this helps: This benefits manufacturers looking for sustainable packaging solutions.

Plain English
This study looked at how temporary mechanical devices to support heart function can help patients suffering from cardiogenic shock, particularly in Brazil. Out of 49 patients treated, the overall death rate was high at 61%, but it dropped significantly to 40% in later treatments as medical teams gained experience. This matters because it shows that with practice, healthcare providers can improve survival rates for patients with heart emergencies even in places with fewer resources. Who this helps: This benefits patients experiencing cardiogenic shock and the doctors treating them.

Plain English
This study looked at how well the New York Heart Association (NYHA) system for classifying heart failure works, especially among patients with mild forms of the disease. Researchers compared different tests and measures in 188 heart failure patients; they found that even though 65% were classified as the least severe (class I) and 35% as slightly more severe (class II), many had similar levels of physical capability and symptoms. For example, the average distance walked in six minutes was 400 meters for class I and 351 meters for class II, showing significant overlap and suggesting that the NYHA classification may not accurately reflect the severity of heart failure in these patients. Who this helps: This information benefits patients and doctors by improving the understanding of heart failure severity.

Plain English
This study examined how diet affects an enzyme called paraoxonase 1 (PON1) in patients with cardiovascular disease (CVD). Researchers found that patients with lower PON1 activity tended to consume more cholesterol and saturated fats, with significant links to dietary fat intake and blood pressure. Better nutrition can help improve PON1 levels, which is important for protecting against heart disease. Who this helps: Patients with cardiovascular disease.

Plain English
This study looked at how the movement of a heart structure called the atrial septum is affected when the aortic root, a part of the heart's major artery, enlarges. Researchers analyzed data from 336 patients and found that, on average, the atrial septum moved by 3.4 mm, with more movement occurring as the aortic root diameter increased—specifically, a 1.0 mm increase in septal movement for every 10 mm increase in aortic root diameter. These findings are important because they suggest that changes in the aortic root can impact heart function and potentially the risk of stroke. Who this helps: This helps patients with heart conditions and doctors working to prevent strokes.

Plain English
Researchers studied a new system that sends patients with heart failure automated text messages and offers phone support after they leave the hospital. They found that this approach, involving daily messages for the first 30 days, could potentially improve heart health and quality of life; they measured this by tracking levels of a blood marker (NT-proBNP) and patient feedback. This matters because it can help heart failure patients manage their condition better, reduce hospital readmissions, and ultimately save lives. Who this helps: This helps patients with heart failure and their healthcare providers.

Plain English
This research focused on two proteins, Aurora A (AURKA) and TPX2, to see if they could be targeted for treatment in pancreatic cancer linked to KRAS mutations, which are present in over 90% of these cancer cases. The study found that tumors had significantly higher levels of AURKA and TPX2 compared to normal tissues, and patients with high levels of these proteins had shorter survival rates. Targeting AURKA or TPX2 reduced cancer cell growth and movement, suggesting these proteins could be important for developing new treatments for this aggressive cancer. Who this helps: This research helps patients with KRAS-induced pancreatic cancer.

Plain English
This study looked at how drinking sugary drinks affects health factors like weight and blood sugar in people with heart disease. Researchers found that those who consumed sugar-sweetened beverages had higher body mass index (BMI), larger waist sizes, and elevated triglyceride levels, with significant differences noted in their measurements (for instance, p=0.004 for waist circumference). This matters because it highlights the importance of reducing sugary drink intake to improve health outcomes in patients already dealing with heart issues. Who this helps: This helps patients with heart disease and their doctors in guiding dietary choices.

Plain English
The study looked at how common metabolic syndrome is among patients with existing heart artery disease (atherosclerosis) and what risk factors are most important. Out of 82 patients, about 84% had metabolic syndrome, with being overweight increasing their risk by 0.64 points, and being a current or former smoker increasing it by 0.48 points. This is important because it shows that managing weight and avoiding smoking can help lower the chances of serious heart-related issues in these patients. Who this helps: This helps patients with atherosclerosis and their doctors.

Plain English
This study looked at a nutrition program called the BALANCE Program aimed at helping heart disease patients improve their diets and reduce the risk of serious heart events. Researchers tracked over 2,500 patients for about 3.5 years and found that while the BALANCE group ate slightly healthier—with a higher average score on a healthy eating scale (26.2 vs. 24.7)—there was no significant difference in heart-related events or deaths between those on the program and those receiving standard dietary advice. This matters because it suggests that simply providing nutritional education may not be enough to prevent heart attacks or deaths in patients already diagnosed with heart disease. Who this helps: This helps patients with cardiovascular disease seeking better dietary advice.

Plain English
In this study, researchers looked at whether it is safe for stable patients with mild heart failure to stop taking a low dose of the diuretic furosemide. They found that withdrawing the diuretic did not worsen patients' shortness of breath and that 75.3% of those who stopped using it did not need to start it again during follow-up, which is similar to the 83.7% who continued the medication. This matters because it suggests that some patients might manage just as well without diuretics, potentially leading to simpler treatment plans. Who this helps: This helps patients with mild heart failure who may not require long-term diuretic treatment.

Plain English
This research looked at different tests for diagnosing stable coronary artery disease (CAD) in patients with varying levels of risk, comparing methods like exercise ECG, stress echocardiogram, CT angiography, and others. The study found that using CT angiography or stress echocardiogram as the first test was the best option for diagnosing CAD effectively at a reasonable cost, costing about $286 to $305 per correct diagnosis, while exercise ECG tests were cheaper but less reliable. This is important because choosing the right testing strategy can save money and reduce unnecessary procedures in healthcare systems. Who this helps: This helps patients with stable chest pain and healthcare providers in developing countries.

Plain English
This study looked at a genetic change called the t(14;18) translocation in healthy blood donors in Brazil, a diverse country with many ethnic backgrounds. Researchers found that 52.94% of White individuals, 79.17% of Black individuals, and 97.14% of those of Japanese descent had this translocation. Understanding how common this translocation is in different ethnic groups helps doctors assess genetic risks and improve health care. Who this helps: This benefits doctors and researchers studying genetic health risks in diverse populations.

Plain English
This study looked at whether it's safe for stable heart failure patients to stop taking furosemide, a diuretic medicine commonly used to relieve symptoms. Researchers are enrolling 220 patients who have been taking a steady dose of furosemide for at least six months, and they will compare those who continue taking the drug with those who stop it. The results will help determine if withdrawing from furosemide can be done safely without worsening patients' conditions, which is important for simplifying heart failure treatments. Who this helps: This helps heart failure patients and their doctors make informed decisions about medication use.

Plain English
The BALANCE Program Trial is a study in Brazil aimed at improving heart health for people over 45 who have cardiovascular disease. It tests a special dietary program focused on nutritious, budget-friendly foods and offers consistent support through personal meetings and phone check-ins. The study will include 2,468 participants to see if this program can lower serious heart-related health issues, such as heart attacks and strokes, over four years. Who this helps: This helps patients with cardiovascular disease.

Plain English
This study looked at different tests used to diagnose coronary artery disease in patients with stable chest pain and analyzed which options were the most cost-effective. The researchers found that switching from exercise electrocardiography to computed tomography angiography offered better health outcomes for a cost of about 3100 international dollars for each additional year of healthy life gained. They concluded that coronary CT is a good option for the Brazilian public health system, while stress echocardiography is also a solid, affordable alternative for most patients. Who this helps: This benefits doctors making diagnostic decisions and patients seeking accurate, cost-effective testing options.

Plain English
This study looked at whether three drugs used to treat psoriatic arthritis—adalimumab, etanercept, and infliximab—should be included in the National Formulary of Uruguay for patients who didn’t benefit from standard treatments. The researchers found that infliximab provided some benefits, costing about $47,294 for each year of improved quality of life, but this cost is too high compared to what the health system can afford. Access to infliximab is also a concern since it requires intravenous use, which may limit treatment for patients in different areas. Who this helps: This helps patients with psoriatic arthritis who may need more effective treatment options.

Plain English
This study looked at the costs and benefits of using cardiac resynchronization therapy (CRT) for patients with heart failure in Brazil. The researchers found that CRT improves patients' quality of life and survival at a cost of around Int$ 15,723 for each additional year lived in good health. Although combining CRT with another device called an implantable cardioverter-defibrillator (ICD) is effective, it is more expensive and may not always be a good value considering Brazil's economic situation. Who this helps: This information benefits patients with heart failure and healthcare providers in middle-income countries.

Plain English
This research paper looked at the costs and benefits of different treatments for heart failure, a serious heart condition that affects many people and can lead to hospitalization and death. The authors found that while new treatments and technologies can improve patient care, their high costs put a strain on healthcare systems, making it hard to provide these options to everyone who needs them. Understanding the cost-effectiveness of these therapies is important for making informed decisions about which treatments to use and ensuring the best outcomes for patients. Who this helps: This helps patients with heart failure and their doctors.

Plain English
This study looked at the levels of a heart-related marker, NT-proBNP, in patients undergoing surgery that didn’t involve the heart, specifically those at higher risk for heart problems. Researchers found that 11.7% of the 145 patients experienced serious heart issues after surgery, and high levels of NT-proBNP before surgery were linked to a greater chance of these events (an odds ratio of 4.2). This information is important because measuring NT-proBNP before surgery can help predict which patients might face heart complications, allowing for better pre-surgery planning. Who this helps: This helps doctors by improving patient safety during noncardiac surgeries.

Plain English
This study looked at how a sensitive test for cardiac troponin I (cTnI) could help predict heart issues in patients undergoing nonheart surgery who are at risk for complications. The researchers tested 142 patients and found that 47 had elevated cTnI levels, with 14 of those diagnosed with a heart attack. After 30 days, 16 patients experienced major heart problems, and the levels of cTnI were good at predicting these outcomes, showing a sensitivity of 94% and an accuracy rate of nearly 89%. This is important because it means that measuring cTnI can help doctors better assess and manage heart-related risks in patients before and after surgery. Who this helps: This helps patients undergoing surgery, especially those with existing heart risks.

Plain English
This study focused on a woman with advanced poorly differentiated thyroid cancer that had spread to her heart, which is a rare occurrence. The use of echocardiography and magnetic resonance imaging helped diagnose these heart metastases, emphasizing that these imaging techniques are valuable for identifying similar cases. Understanding this type of cancer spread is important because it can affect treatment decisions and patient outcomes. Who this helps: This helps patients with advanced thyroid cancer and their doctors by improving diagnosis and treatment strategies.

Plain English
This research studied how combining cardiac resynchronization therapy (CRT) with implantable cardioverter-defibrillator (ICD) therapy affects the survival of heart failure (HF) patients. The analysis included 12 studies with over 8,200 patients and found that this combination therapy reduced the risk of death by 17% compared to using ICD alone, and by 24% in more severe cases of heart failure. These findings are important because they suggest that patients with heart failure may live longer when treated with both CRT and ICD therapies rather than just ICD alone. Who this helps: Heart failure patients, particularly those with more severe conditions.

Plain English
Researchers reviewed how bone infections in the spine develop, how doctors diagnose them, and how to treat them most effectively. These infections usually spread through the bloodstream and commonly affect the lower back in younger people and the mid-back in tuberculosis cases; older adults are getting them more often, usually from contaminated IV lines or urinary tract infections, while younger patients are getting them from drug use, heart valve infections, or tuberculosis from endemic regions. Diagnosing these infections is challenging because symptoms—like back pain and fever—appear slowly and can be mild or vague, often causing a 2-4 month delay before diagnosis, but doctors should start treatment with antibiotics and spine immobilization first, only turning to surgery if the patient doesn't improve after 2-3 weeks, has ongoing pain, develops nerve damage, or shows spine collapse.

Plain English
This study looked at how effective a specific type of surgery, called locked nailing, is for treating subtrochanteric fractures in elderly patients. Researchers treated 59 patients, mainly women, and found that after using a Gamma nail for fixation, patients began to put weight on their injured leg after an average of 20 days and fully walk on it after 60 days, with the bones healing in about 4 months. Importantly, there were few complications, although 11 patients died within six months, highlighting the risks involved with this age group. Who this helps: This research benefits elderly patients with fractures and their healthcare providers by offering a safer surgical option.

Plain English
This research examined a new device called the Fixion nail, a stainless steel implant used to treat fractures in the lower limbs. The study involved 19 patients and showed that most were able to start putting weight on their injured limbs after about 7 days, and nearly everyone had their fractures heal within 18 days. This is important because it offers a quick and effective way to stabilize fractures, helping people recover faster from their injuries. Who this helps: This helps patients with lower limb fractures.